Author: SilanAdmin


by SilanAdmin SilanAdmin No hay comentarios


The philosophy of our meeting is persistent with ‘all’ live cases accompanied by open discussion and it rotates around the world, from one continent to the other each year.

This conference is designed for neurosurgeons, interventional neuroradiologists, neurologists, endovascular surgeons, residents, nurse clinicians, physician assistants and interventional technicians, and other health care professionals with a special interest in the field of neurointerventional and cerebrovascular surgery and will be directly applicable to their practices.

WLNC provides the latest evidence-based data presented by leading physicians, nurses, and scientists that will affect the practice of neurointervention and endovascular medicine. WLNC showcases the practical applications of current and emerging techniques and technologies and unparalleled diversity of live-case presentations from universities and medical centers from around the world. In the field of neurointervention, only WLNC combines the hands on and practical learning that physicians need to improve patient outcomes.

The overall goal of this activity is to improve competence and performance of our target audience by delivering cutting-edge educational content that showcases the latest advances in current therapies and clinical research. We hope that our longstanding commitment to lifesaving innovation will translate into improved patient care.

This conference is partially funded through educational grants from commercial supporters. The Cerebrovascular Research and Educational Foundation (CREF) ensure that its programs are educational and meet the needs of the target audience. To support this endeavor, the directors and co-directors of WLNC create organizational and scientific committees to assist in the development and oversight of educational content for live cases, e-poster sessions, practical workshops (learning labs), and scientific lectures. These sessions are developed without influence from commercial supporters.


WLNC is pleased to offer sponsor companies the opportunity to provide hands-on interactive training to professional attendees of WLNC 2019. Learning Labs are dedicated to creating an intimate educational atmosphere in which physicians and healthcare professionals can interact with a company’s clinical specialist to enhance their knowledge and understanding of treatment techniques and devices.





XXX CONGRESO ANUAL – La Habana, Cuba, 11-14 julio 2018

by SilanAdmin SilanAdmin No hay comentarios


La Sociedad Ibero Latinoamericana de Neurorradiología Diagnóstica y Terapéutica tiene el placer de invitarlos a participar en su XXX CONGRESO ANUAL, a celebrarse en la emblemática Ciudad de La Habana, Cuba, del 11 al 14 de julio del año 2018.

El Congreso se llevará a cabo en el Hotel Meliá Cohíba, representativa instalación de finales del siglo XX, situado en el corazón de El Vedado, uno de los más importantes enclaves residenciales de la ciudad.

Se ha diseñado un programa académico de excelencia de interés para todos ustedes, que contará con sesiones concurrentes de diagnóstico e intervencionismo y un curso pre-congreso.

Como es tradición en los eventos de la SILAN, también contará con un programa social en el que se compartirá la riqueza de la cultura cubana.





2th International Symposium on Mechanical Thrombectomy Acute Stroke (SYMTAS)

by SilanAdmin SilanAdmin No hay comentarios

We are pleased to announce that the 2th International Symposium on Mechanical Thrombectomy Acute Stroke (SYMTAS) will be held from 31th May to 1st June in Santiago de Compostela, Spain. SYMTAS is the successor of “International Symposium on Thrombectomy in Acute Ischemic Stroke”, which was founded by José A Castillo and José M Pumar in 2017.

The symposia have provided opportunities to discuss the possibility of reperfusion therapy and encouraged investigators in many countries to design controlled clinical trials on the efficacy and safety of thrombolytic therapy. The contribution of the symposia is enormous in the development of reperfusion therapy for acute ischemic stroke. Now, Mechanical Thrombectomy  therapy has become a standard therapy for acute stroke for ELVO, has been recently shown to be beneficial in randomized clinical trials and is now regarded as another strategy.

This two-day meeting will provide opportunities for stroke neurologists, neurosurgeons, interventionists, researchers, to meet and discuss both current and future issues related to reperfusion therapy and acute stroke treatment. We will share the update of the current trials and new data from the trials presented at the SYMTAS 2017. We will also address many areas of interest linked to recanalization, including the critical care for such patients, complications, prevention of recurrence, novel devices designs, and relevant strategies. We encourage you to join us, for the meeting and to share your research and exchange views with your peers.

More info: